GlassScriptPhysician profile
Theresa Thiele
NPI 1922023639
$4,534.00
in general payments reported to CMS, 2019-2025
21 companies · $1,011 in 2025
The $1,011 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,072 · 2022: $1,260 · 2024: $1,191 · 2025: $1,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,185 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,185.03 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,939.09 | 2022-2025 | |
| Abbvie INC. | $985.83 | 2021-2025 | |
| Revance Therapeutics, INC. | $508.74 | 2024-2025 | Daxxify |
| Astrazeneca Pharmaceuticals LP | $275.98 | 2021-2022 | |
| Galderma Laboratories, L.P. | $131.28 | 2022-2024 | |
| Glaxosmithkline, LLC. | $110.94 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.54 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $86.40 | 2021 | |
| Amgen INC. | $63.01 | 2021 | |
| Astellas Pharma US INC | $62.83 | 2021 | |
| Abbott Laboratories | $51.38 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.26 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.51 | 2021 | |
| Janssen Pharmaceuticals, INC | $24.88 | 2021-2022 | |
| Dexcom, INC. | $21.88 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.50 | 2021 | |
| Medtronic, INC. | $20.75 | 2021 | |
| Merck Sharp & Dohme LLC | $18.86 | 2021 | |
| Novo Nordisk INC | $17.78 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.03 | 2021 | |
| Clarus Therapeutics INC. | $15.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theresa Thiele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.